Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
979423381000036118 | Clarinase Repetab (loratadine 5 mg + pseudoephedrine sulfate 120 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
979423401000036118 | Clarinase Repetab modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Clarinase Repetab modified release tablet | has intended active ingredient | loratadine | true | Inferred relationship | Some | 901465102 | |
Clarinase Repetab modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Clarinase Repetab modified release tablet | Is a | Clarinase Repetab | true | Inferred relationship | Some | ||
Clarinase Repetab modified release tablet | Is a | loratadine 5 mg + pseudoephedrine sulfate 120 mg modified release tablet | true | Inferred relationship | Some | ||
Clarinase Repetab modified release tablet | has intended active ingredient | pseudoephedrine | true | Inferred relationship | Some | 874857154 | |
Clarinase Repetab modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
Clarinase Repetab modified release tablet | has Australian BoSS | pseudoephedrine sulfate | true | Inferred relationship | Some | 874857154 | |
Clarinase Repetab modified release tablet | has Australian BoSS | loratadine | true | Inferred relationship | Some | 901465102 | |
Clarinase Repetab modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 901465103 |
Reference Sets
Trade product unit of use reference set